There are some molecular events that have been proposed as markers of a more aggressive phenotype of IPMN, such as inactivation of p53 that was found in IPMNs with high grade dysplasia [22]. This evidence concerns the gene TP53 and pancreatic intraductal papillary-mucinous neoplasm.